UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

The clinical significance of patients' sex in chronic lymphocytic leukemia

Haematologica (Roma), 2014-06, Vol.99 (6), p.1088

2014

Volltextzugriff (PDF)

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Blood, 2013-01, Vol.121 (3), p.468-475

2013

Volltextzugriff (PDF)

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

Blood, 2008-02, Vol.111 (4), p.1820-1826

2008

Volltextzugriff (PDF)

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Haematologica (Roma), 2010-10, Vol.95 (10), p.1705-1712

2010

Volltextzugriff (PDF)

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

British journal of haematology, 2012-11, Vol.159 (3), p.322-328

2012

Volltextzugriff (PDF)

Indigenous Peoples, Natural Resources and Governance: Agencies and Interactions

1, 2022

Volltextzugriff (PDF)

Early clinical trials in chronic lymphocytic leukaemia in the UK

British journal of haematology, 2020-11, Vol.191 (4), p.535-541

2020

Volltextzugriff (PDF)

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

Blood, 2007-11, Vol.110 (9), p.3291-3300

2007

Volltextzugriff (PDF)

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes

Haematologica (Roma), 2013-02, Vol.98 (2), p.274-278

2013

Volltextzugriff (PDF)

Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

Clinical cancer research, 2008-10, Vol.14 (19), p.6033-6041

2008

Volltextzugriff (PDF)

Long-term follow-up after purine analogue therapy in hairy cell leukaemia

Best practice & research. Clinical haematology, 2015-12, Vol.28 (4), p.217-229

2015

Volltextzugriff (PDF)

The Association between Deaths Due to Infection and Mutations of the BRAF, FBXW7, NRAS and XPO1 genes: A Report from the LRF CLL4 Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.37-38

2020

Volltextzugriff (PDF)

The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial

Leukemia, 2021-09, Vol.35 (9), p.2563-2569

2021

Volltextzugriff (PDF)

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial

British journal of haematology, 2016-09, Vol.174 (5), p.767-775

2016

Volltextzugriff (PDF)

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Blood, 2017-02, Vol.129 (5), p.553-560

2017

Volltextzugriff (PDF)

The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years

British journal of haematology, 2016-01, Vol.172 (2), p.228-237

2016

Volltextzugriff (PDF)

Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant

British journal of haematology, 2012-01, Vol.156 (2), p.186-195

2012

Volltextzugriff (PDF)

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia

Leukemia & lymphoma, 2011-06, Vol.52 (S2), p.21-24

2011

Volltextzugriff (PDF)

No Improvement in Survival for T-PLL Patients over the Last Two Decades

Blood, 2019-11, Vol.134 (Supplement_1), p.1552-1552

2019

Volltextzugriff (PDF)

The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma

British journal of haematology, 2012-08, Vol.158 (3), p.347-354

2012

Volltextzugriff (PDF)

The long‐term outcome of patients in the LRF CLL 4 trial: the effect of salvage treatment and biological markers in those surviving 10 years

British journal of haematology, 2016-01, Vol.172 (2), p.228-237

2016

Volltextzugriff (PDF)

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Blood, 2011-11, Vol.118 (22), p.5799-5802

2011

Volltextzugriff (PDF)

Chlorambucil—Still Not Bad: A Reappraisal

Clinical lymphoma, myeloma and leukemia, 2011-06, Vol.11, p.S2-S6

2011

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Humans
(52)
Male
(37)
Female
(36)
Hematology
(36)
Aged
(30)
Middle Aged
(28)
Adult
(25)
Oncology
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Aged, 80 And Over
(17)
Prognosis
(17)
Treatment Outcome
(16)
Hematologic And Hematopoietic Diseases
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Mutation
(12)
Antineoplastic Agents - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(25)
British Journal Of Haematology
(13)
Dix-Huitième Siècle
(6)
Leukemia & Lymphoma
(6)
Tidsskrift For Den Norske Lægeforening
(5)
Cancer
(4)
Blood Advances
(3)
Haematologica
(3)
Leukemia
(3)
Evolutionary Applications
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The clinical significance of patients' sex in chronic lymphocytic leukemia

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

Indigenous Peoples, Natural Resources and Governance: Agencies and Interactions

Early clinical trials in chronic lymphocytic leukaemia in the UK

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes

Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

Long-term follow-up after purine analogue therapy in hairy cell leukaemia

The Association between Deaths Due to Infection and Mutations of the BRAF, FBXW7, NRAS and XPO1 genes: A Report from the LRF CLL4 Trial

The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years

Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia

No Improvement in Survival for T-PLL Patients over the Last Two Decades

The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma

The long‐term outcome of patients in the LRF CLL 4 trial: the effect of salvage treatment and biological markers in those surviving 10 years

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Recurrent CDKN1B (p27) mutations in hairy cell leukemia

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial

Chlorambucil—Still Not Bad: A Reappraisal

Suchergebnisse filtern